Aadhaar A Monolith, A System With No Choices, Kapil Sibal Argues For Petitioners
With the Aadhaar biometric identification system, the government is creating “a monolith, a system with no choices”, argued Senior Advocate Kapil Sibal in the Supreme Court today.
The outcome of the Aadhaar hearing will have huge implications on the future of this country, said Sibal, the second lawyer to argue on behalf of petitioners challenging the constitutional validity of Aadhaar. He built his arguments on the grounds that choice is a fundamental element of the rights guaranteed under the Constitution and the concept of Aadhaar violates that.
Identity is a matter of proof but “when we want to state our identity, the State says we can do it only in one particular way”, Sibal argued further before the five-judge Constitution bench headed by the Chief Justice of India.
Also Read: Has Aadhaar Worked For Rural India?
In the first half of the day, Senior Advocate Shyam Divan, who is also arguing on behalf of petitioners, summarised his arguments. Divan touched upon the concept of exclusion in the context of Aadhaar. The insistence on this biometric identity leads to the exclusion of certain people who would otherwise be entitled to receive their rights and benefits, he said.
About 6.23 crore enrollments have been rejected due to biometric duplication, Divan said in support of his statement, adding that many others have not been able to enroll themselves. This has led to exclusion, he argued.
In a digital world, personal autonomy extends to biometrics. The control over that has to rest with citizens and not the state, except in a few circumstances.Shyam Divan, Senior Advocate
Sibal will continue his arguments tomorrow.
Also Read: Aadhaar Is An Architecture For Mass Surveillance, Petitioners Argue
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.